LGR6 and ovarian cancer: The previous results indicated that overexpression of LGR6 was positively correlated with poor chemotherapeutic response in ovarian cancer patients, to which CSCs have been reported to contribute.6, 7 Therefore, we further examined the effects of LGR6 on therapeutic response of ovarian cancer cells to different chemotherapies commonly used in ovarian cancer patients.